Vitamin D deficiency and length of pediatric intensive care unit stay: a prospective observational study

Jhuma Sankar1, Wonashi Lotha2, Javed Ismail3

  • 1Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India. jhumaji@gmail.com.

Annals of Intensive Care
|January 10, 2016
PubMed

Insights

Critically ill children admitted to the intensive care unit (ICU) have a high prevalence of vitamin D deficiency. This deficiency is associated with a significantly longer ICU stay, indicating its potential role in disease severity.

Area of Science:

  • Pediatric Critical Care Medicine
  • Nutritional Science
  • Clinical Research

Background:

  • Limited data exists on vitamin D status in pediatric intensive care unit (ICU) patients.
  • The role of vitamin D in critically ill children remains debated, with uncertainty about whether it's a marker of disease severity or an independent factor.
  • Interventional studies are lacking to confirm if vitamin D supplementation improves outcomes in this population.

Purpose of the Study:

  • To determine the prevalence of vitamin D deficiency in children admitted to the ICU.
  • To investigate the association between vitamin D deficiency and clinical outcomes, specifically the duration of ICU stay.

Main Methods:

  • A prospective study enrolled 101 children aged 1 month to 17 years admitted to the ICU over 8 months.
  • Vitamin D deficiency was defined as serum 25-hydroxyvitamin D levels below 20 ng/mL at admission.
  • The primary endpoints were the prevalence of deficiency and its association with length of ICU stay.

Main Results:

  • A high prevalence of vitamin D deficiency was observed in 74% of the pediatric ICU patients.
  • Children with vitamin D deficiency had a significantly longer median ICU stay (7 days) compared to those without deficiency (3 days).
  • Multivariable analysis confirmed that vitamin D deficiency was independently associated with a longer ICU stay (adjusted mean difference: 3.5 days), even after controlling for severity scores and other clinical factors.

Conclusions:

  • Critically ill children admitted to the ICU exhibit a high prevalence of vitamin D deficiency.
  • Vitamin D deficiency is significantly associated with an increased duration of ICU stay in this pediatric population.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
372
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
733
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
461
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
702
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
609
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.8K